Biodistribution Data of [99mTc]Demogastrin 1–3 in AR4-2J Tumor-Bearing Athymic Mice as %ID/g Tissue (Mean ± SD)
Organ | [99mTc]Demogastrin 1 | [99mTc]Demogastrin 2 | [99mTc]Demogastrin 3 | ||||
---|---|---|---|---|---|---|---|
1 h pi | 4 h pi | 1 h pi | 4 h pi | 1 h pi | |||
Blood | 0.36 ± 0.10 | 0.15 ± 0.01 | 0.17 ± 0.02 | 0.03 ± 0.00 | 0.35 ± 0.06 | ||
Liver | 0.34 ± 0.05 | 1.04 ± 0.09 | 0.63 ± 0.20 | 0.38 ± 0.03 | 2.61 ± 0.49 | ||
Heart | 0.15 ± 0.04 | 0.09 ± 0.02 | 0.30 ± 0.18 | 0.04 ± 0.00 | 0.28 ± 0.06 | ||
Kidneys | 78.97 ± 1.60 | 41.08 ± 4.21 | 83.92 ± 14.45 | 42.65 ± 4.18 | 78.18 ± 11.85 | ||
Blocked kidneys | 17.78 ± 0.07† | 20.95 ± 1.27* | 27.95 ± 6.49* | 14.03 ± 1.84† | 19.50 ± 3.84* | ||
Stomach | 6.59 ± 0.50 | 3.47 ± 0.23 | 5.86 ± 0.28 | 3.96 ± 0.26 | 5.96 ± 0.49 | ||
Blocked stomach | 1.06 ± 0.08† | 0.45 ± 0.17† | 0.43 ± 0.01† | 0.16 ± 0.03† | 0.41 ± 0.10† | ||
Intestine | 0.62 ± 0.19 | 1.07 ± 0.16 | 0.44 ± 0.02 | 0.54 ± 0.04 | 0.37 ± 0.03 | ||
Spleen | 0.17 ± 0.02 | 0.22 ± 0.40 | 0.13 ± 0.03 | 0.10 ± 0.01 | 0.33 ± 0.09 | ||
Muscle | 0.12 ± 0.05 | 0.09 ± 0.00 | 0.09 ± 0.07 | 0.02 ± 0.01 | 0.12 ± 0.05 | ||
Lung | 0.37 ± 0.05 | 0.18 ± 0.02 | 0.54 ± 0.29 | 0.06 ± 0.01 | 0.45 ± 0.09 | ||
Pancreas | 0.28 ± 0.05 | 0.13 ± 0.01 | 0.22 ± 0.10 | 0.09 ± 0.02 | 0.23 ± 0.02 | ||
AR4-2J tumor | 6.13 ± 3.28 | 2.70 ± 1.12 | 5.50 ± 0.85 | 2.88 ± 0.42 | 4.20 ± 1.22 | ||
Blocked tumor | 0.94 ± 0.42* | 0.34 ± 0.01* | 0.45 ± 0.07† | 0.17 ± 0.00† | 0.52 ± 0.11* |
Student t test was used for statistical analysis; a P value of <0.01 (
↵* P) was considered very significant, whereas a P value of <0.001 (
↵† P) was considered extremely significant.
pi = after injection.
Results are average of 4 animals per group. Blocking was achieved by coinjection of 250 μg [(D)Glu1]minigastrin.